Korea
Featured book
Shapers and Founders
Drawing on rigorous empirical research, interviews, and decades of advisory work, McKinsey experts reveal the leadership strategies behind Asia’s highest-performing entrepreneur-led companies.
Featured Insights
Korea’s next S-curve: A new economic growth model for 2040
-
Currently faced with a stagnating economy, South Korea could grow to become a top-seven economy by 2040 by adopting eight bold actions within three pillars.
The emerging epicenter: Asia’s role in biopharma’s future
-
Asia is now the epicenter of global biopharmaceutical progress—outpacing the United States and Europe in pipeline growth,...
Economic conditions outlook, December 2025
-
In a reversal from earlier in the year, economic sentiment turns more optimistic, with declining focus on trade policy and growing...
More Insights
Report
Global Banking Annual Review 2026: Precision with speed
Global Banking Annual Review 2026: Precision with speed
-
In this preview of our 2026 Global Banking Annual Review, we provide a glimpse of banks’ continued strong results in...
The next age of fintech: AI, digital assets, and new paths to success
-
Fintechs are now generating $650 billion in revenue, and the most successful ones are balancing scale, profitability, and new-found...
Beyond $1 trillion: The next chapter for insurance and private capital
Beyond $1 trillion: The next chapter for insurance and private capital
-
Private-capital-backed insurers, whose assets totaled nearly $1.5 trillion in 2025, have reshaped the life insurance industry...
A Century of Plenty
-
Can you imagine even the poorest country in the world achieving the prosperity and quality of life of today’s Switzerland—by...
State of Food and Beverage: The choices CPG leaders can make to renew growth
-
The slow erosion of value in the consumer goods industry is now speeding up. Leaders need to reshape their portfolios, sharpen...
Report
Geopolitics and the geometry of global trade: 2026 update
-
Tariff splashes, AI waves, and the ripples reshaping global trade.
The emerging epicenter: Asia’s role in biopharma’s future
-
Asia is now the epicenter of global biopharmaceutical progress—outpacing the United States...









